63 related articles for article (PubMed ID: 2573218)
1. [The beta-blocker effect of the blood serum in patients with psoriasis].
Sokolovskiĭ EV; Raznatovskiĭ IM; Tret'iakova NN
Vestn Dermatol Venerol; 1989; (7):6-7. PubMed ID: 2573218
[TBL] [Abstract][Full Text] [Related]
2. [Effect of hemosorption on the anti-chalone properties of the blood serum of patients with psoriasis].
Khvatov EV; Ketlinskiĭ SA; Tret'iakova NN; Simbirtsev AS; Shostka GD
Vestn Dermatol Venerol; 1988; (4):10-2. PubMed ID: 2970719
[No Abstract] [Full Text] [Related]
3. [Blockade of adrenoreceptors--a mechanism for impairing the humoral and cellular regulation of the proliferation of epidermal cells in psoriasis].
Raznatovskiĭ IM; Khvatov EV; Egorov VIa
Biull Eksp Biol Med; 1988 Apr; 105(4):488-91. PubMed ID: 2965923
[No Abstract] [Full Text] [Related]
4. [Biological activity of epidermal chalones in the presence of blood serum from patients with psoriasis].
Tret'iakova NN
Biull Eksp Biol Med; 1984 Jun; 97(6):754-5. PubMed ID: 6234950
[TBL] [Abstract][Full Text] [Related]
5. [Role of microcirculatory pathology and chalone regulation of epidermal cell proliferation in the pathogenesis of psoriasis].
Dosychev EA; Eletskaia LV; Moshkalova IA; Topol'nitskiĭ NF; Tret'iakova NN
Vestn Dermatol Venerol; 1983 Aug; (8):13-6. PubMed ID: 6227154
[No Abstract] [Full Text] [Related]
6. [Epidermic and lymphocytary chalone receptors in psoriasis].
Vignale RA; Lasalvia E; Espasandin J; Borras A
Med Cutan Ibero Lat Am; 1983; 11(4):233-40. PubMed ID: 6314069
[TBL] [Abstract][Full Text] [Related]
7. [Psoriasis and beta-blockade].
Steinkraus V; Mensing H
Hautarzt; 1992 Apr; 43(4):179-83. PubMed ID: 1350775
[TBL] [Abstract][Full Text] [Related]
8. IL-1 beta and IFN-gamma induce the regenerative epidermal phenotype of psoriasis in the transwell skin organ culture system. IFN-gamma up-regulates the expression of keratin 17 and keratinocyte transglutaminase via endogenous IL-1 production.
Wei L; Debets R; Hegmans JJ; Benner R; Prens EP
J Pathol; 1999 Feb; 187(3):358-64. PubMed ID: 10398092
[TBL] [Abstract][Full Text] [Related]
9. [Modifying effect of the blood serum of patients with psoriasis on the inhibitory activity of epidermal chalones].
Dosychev EA; Ketlinskiĭ SA; Tret'iakova NN
Vestn Dermatol Venerol; 1981 Mar; (3):18-20. PubMed ID: 6455018
[No Abstract] [Full Text] [Related]
10. CNS adrenergic receptors and beta blockade.
Mann JJ; Arango V
Postgrad Med; 1988 Feb; Spec No():135-9. PubMed ID: 2894655
[TBL] [Abstract][Full Text] [Related]
11. Serum and tissue expression of transforming growth factor beta 1 in psoriasis.
Zaher H; Shaker OG; EL-Komy MH; El-Tawdi A; Fawzi M; Kadry D
J Eur Acad Dermatol Venereol; 2009 Apr; 23(4):406-9. PubMed ID: 19175705
[TBL] [Abstract][Full Text] [Related]
12. [The pathogenesis of psoriasis].
Nikitin AF; Legostev BI; Sergievskaia IV
Vestn Dermatol Venerol; 1990; (5):38-40. PubMed ID: 2169685
[TBL] [Abstract][Full Text] [Related]
13. Levobetaxolol (Betaxon): in vitro pharmacology, intraocular pressure lowering activity and autoradiographic localization of beta-adrenoceptors in human eyes.
Sharif NA; Crider JY; Xu SX; McLaughlin M; Davis TL
Proc West Pharmacol Soc; 2001; 44():65-8. PubMed ID: 11793997
[No Abstract] [Full Text] [Related]
14. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
Krasnikova TL; Radiukhin VA; Parfenova EV; Suvorov IuI; Ustinova SE
Biull Eksp Biol Med; 1986 Jul; 102(7):46-8. PubMed ID: 2873850
[TBL] [Abstract][Full Text] [Related]
15. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
Molenaar P; Sarsero D; Arch JR; Kelly J; Henson SM; Kaumann AJ
Br J Pharmacol; 1997 Jan; 120(2):165-76. PubMed ID: 9117106
[TBL] [Abstract][Full Text] [Related]
16. The mechanism of lithium and beta-blocking agents in inducing and exacerbating psoriasis.
O'Brien M; Koo J
J Drugs Dermatol; 2006 May; 5(5):426-32. PubMed ID: 16703778
[TBL] [Abstract][Full Text] [Related]
17. 7-Chloro-5-(4-hydroxyphenyl)-1-methyl-3-(naphthalen-2-ylmethyl)-4,5-dihydro-1H-benzo[b][1,4]diazepin-2(3H)-one (Bz-423), a benzodiazepine, suppresses keratinocyte proliferation and has antipsoriatic activity in the human skin-severe, combined immunodeficient mouse transplant model.
Bhagavathula N; Nerusu KC; Hanosh A; Aslam MN; Sundberg TB; Opipari AW; Johnson K; Kang S; Glick GD; Varani J
J Pharmacol Exp Ther; 2008 Mar; 324(3):938-47. PubMed ID: 18055879
[TBL] [Abstract][Full Text] [Related]
18. [Epidermic chalone receptors in psoriasis treated with retinoid:Ro 10-9359].
Vignale RA; Lasalvia E; Espasandín J; Borras A
Med Cutan Ibero Lat Am; 1983; 11(4):241-6. PubMed ID: 6314070
[TBL] [Abstract][Full Text] [Related]
19. Coexistence of beta-1 and beta-2 adrenergic receptors in the human heart: effects of treatment with receptor antagonists or calcium entry blockers.
Hedberg A; Kempf F; Josephson ME; Molinoff PB
J Pharmacol Exp Ther; 1985 Sep; 234(3):561-8. PubMed ID: 2863366
[TBL] [Abstract][Full Text] [Related]
20. Antigen-independent expansion of T cells from psoriatic skin lesions: phenotypic characterization and antigen reactivity.
Horrocks C; Holder JE; Berth-Jones J; Camp RD
Br J Dermatol; 1997 Sep; 137(3):331-8. PubMed ID: 9349325
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
